The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review

2024-9-11

Lipid metabolism reprogramming in renal cell carcinomas

2024-9-6

Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy

2024-9-5

Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review

2024-9-5

The role of IL-22 in cancer

2024-9-4

Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology

2024-9-4

How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review

2024-9-1

Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”

2024-8-30

Letter to the editor: comment on “Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study”

2024-8-29

The treatment landscape of triple-negative breast cancer

2024-8-29

Letter to the editor: Comment on “Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment”

2024-8-23

The potential of lenvatinib in breast cancer therapy

2024-8-22

2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α

2024-8-21

Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer

2024-8-20

A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms

2024-8-19

2023 ACS – LANA lymphedema summit forward momentum; future steps in lymphedema management

2024-8-19

Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects

2024-8-17

Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma

2024-8-14

Letters to editor regarding the article “P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway”

2024-8-13

Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients

2024-8-13

Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins

2024-8-9

Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes

2024-8-9

Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review

2024-8-9

Emerging roles of the chromatin remodeler MORC2 in cancer metabolism

2024-8-8

Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells

2024-8-8

Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study

2024-8-6

Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay

2024-8-5

Comment on “Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer”

2024-8-5

Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles

2024-8-5

Targeted gene therapy for cancer: the impact of microRNA multipotentiality

2024-8-1

Comment on ‘Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression’

2024-8-1

Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines

2024-7-30

Mining parasites for their potential as novel therapeutic agents against cancer

2024-7-29

Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma

2024-7-29

Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer

2024-7-26

Current advances in cancer energy metabolism under dietary restriction: a mini review

2024-7-26

Allicin: a promising modulator of apoptosis and survival signaling in cancer

2024-7-26

PARK2 suppresses the proliferation of high-grade serous ovarian carcinoma via inducing the proteasomal degradation of ZNF703

2024-7-23

Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study

2024-7-22

Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer

2024-7-22

Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells

2024-7-20

Therapeutic and diagnostic applications of exosomes in colorectal cancer

2024-7-20

The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy

2024-7-15

Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations

2024-7-13

Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment

2024-7-11

Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer

2024-7-10

Utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in elderly patients: a retrospective cohort study

2024-7-9

Molecular docking aided machine learning for the identification of potential VEGFR inhibitors against renal cell carcinoma

2024-7-9

Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial

2024-7-8

A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure

2024-7-5